500
Participants
Start Date
May 5, 2023
Primary Completion Date
March 31, 2025
Study Completion Date
June 30, 2025
SGLT2i, beta blocker, ARNI, MRA, MTD
"Immediate initiation of guideline-directed medical therapy. Will also immediately receive the same educational services provided in the Education-First intervention."
Education-First
For the first 3-months of their participation, patients in this arm will receive curated patient education, an alert to providers, provider education, and then after 3 months, be invited to participate in the remote heart failure clinic. The patient education would consist of curated video content and informational worksheets provided by email or secure patient messaging. Provider alerts would happen through notifying of a patient's eligibility for heart failure therapy. Provider education will also consist of the program's medical algorithm and a summary sheet on indications, outcomes, prescribing, and monitoring information
RECRUITING
Brigham and Women's Hospital, Boston
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Eli Lilly and Company
INDUSTRY
Brigham and Women's Hospital
OTHER